您的当前位置:首页 > 行业数据 > 图16、小细胞肺癌各阶段美国患者数与塔拉妥单抗相关的临床布局
图片属性
图片格式:PNG 图片大小:290KB 图片尺寸:1748*719
同报告图片
 / 4
图16、小细胞肺癌各阶段美国患者数与塔拉妥单抗相关的临床布局_第1页
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
图16、小细胞肺癌各阶段美国患者数与塔拉妥单抗相关的临床布局_第2页
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
图16、小细胞肺癌各阶段美国患者数与塔拉妥单抗相关的临床布局_第3页
图16、小细胞肺癌各阶段美国患者数与塔拉妥单抗相关的临床布局_第4页
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
图16、小细胞肺癌各阶段美国患者数与塔拉妥单抗相关的临床布局_第5页
所属报告: 泽璟制药(688266)-A股公司研究报告:在研管线临床优势突出商业化产品稳步推进-250815(36页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠